Moderna, Inc. (MRNA) /

The revenue of Moderna, Inc. over the past 10 years

Chart Moderna, Inc.: revenue, fiscal 2016–2025 Open the chart →

Moderna, Inc. reported revenue of $1.94B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $108.4M — up 1693% over 9 years. Year over year, revenue rose 4 times and fell 5 times. In these years the highest was $19.26B in fiscal 2022; the lowest $60M in fiscal 2019. The largest one-year move was in fiscal 2021: up 2200%, from $803M to $18.47B.

Year by year

Fiscal yearRevenue
2025ended Dec 31, 2025$1.94B
2024ended Dec 31, 2024$3.24B
2023ended Dec 31, 2023$6.85B
2022ended Dec 31, 2022$19.26B
2021ended Dec 31, 2021$18.47B
2020ended Dec 31, 2020$803M
2019ended Dec 31, 2019$60M
2018ended Dec 31, 2018$135.07M
2017ended Dec 31, 2017$205.82M
2016ended Dec 31, 2016$108.4M

Fiscal years as Moderna, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Moderna, Inc.

Companies of a similar size

Not investment advice. This page shows what Moderna, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.